| typ : |
Czasopismo |
| link internetowy : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=4147 |
|
| Zespoły badawcze : |
Columbus - The Ohio State University Hospitals, Department of Pharmacy |
| Autorzy : |
Nahata M C. |
| Tytuł : |
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children. |
| Numer : |
Int J Pharm Compound ; 30, 3 : 247-249. 2016 |
|
| Poziom wiarygodności : |
|
| stabilność fizyczną : |
|
| Stabilność chemiczna : |
|
| Inne metody : |
|
| Komentarze : |
|
Listy
 Morphine sulfate
|
 |
 |
 |
 |
0,2 mg
® = Morphine elixir (Roxane laboratories) |
|
25°C |
 |
| 60 |
 |
|
|
|
|
Sildenafil citrate
|
 |
|
 |
 |
75 mg
Revatio® |
| OraPlus® / OraSweet® (1:1) |
>>30 ml |
|
25°C |
|
| 91 |
|
|
|
|
|
|
75 mg
Revatio® |
| Syrop prosty |
21 ml |
| Metyloceluloza |
1% 3 ml |
|
25°C |
|
| 91 |
|
|
|
|
|
|
75 mg
Revatio® |
| OraPlus® / OraSweet® (1:1) |
>>30 ml |
|
4°C |
|
| 91 |
|
|
|
|
|
|
75 mg
Revatio® |
| Syrop prosty |
21 ml |
| Metyloceluloza |
1% 3 ml |
|
4°C |
|
| 91 |
|
|
|
|
|
